PD holder plans sale of 398,947 shares

Reporting person Jennifer Gail Tejada filed a notice to sell 398,947 shares of the issuer’s common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $4,288,680.25, targeting sales around July 16, 2026 on the NYSE.

Rhea-AI Filing Summary

Reporting person Jennifer Gail Tejada filed a notice to sell 398,947 shares of the issuer’s common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $4,288,680.25, targeting sales around July 16, 2026 on the NYSE. The notice references 77,122,565 shares outstanding.

It also lists 10b5-1 sales in the prior three months: 105,101 shares on May 19, 2026 for $727,383.00 and 358,400 shares on May 18, 2026 for $2,502,563.84.

Key Figures

Shares proposed for sale: 398947 Aggregate market value: 4288680.25 Shares outstanding: 77122565 +5 more

8 metrics

Shares proposed for sale 398947 Common stock to be sold through broker Morgan Stanley Smith Barney LLC

Aggregate market value 4288680.25 Aggregate market value of the 398,947 shares proposed for sale

Shares outstanding 77122565 Shares outstanding for the issuer’s common stock referenced in the notice

Approximate sale date 07/16/2026 Approximate date when the proposed sale of common stock may occur

Shares sold on 05/19/2026 105101 Common shares sold in a 10b5-1 sale on 05/19/2026

Value of 05/19/2026 sale 727383.00 Dollar amount for the 10b5-1 sale on 05/19/2026

Shares sold on 05/18/2026 358400 Common shares sold in a 10b5-1 sale on 05/18/2026

Value of 05/18/2026 sale 2502563.84 Dollar amount for the 10b5-1 sale on 05/18/2026

Key Terms

10b5-1, Exercise of Stock Options, Securities To Be Sold

3 terms

10b5-1 regulatory

"10b5-1 Sales for JENNIFER GAIL TEJADA 600 Townsend St., Suite 200"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 07/16/2026 | Exercise of Stock Options | Issuer"

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 07/16/2026 | Exercise of Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PD common shares are proposed for sale in this Form 144?

The notice covers a proposed sale of 398,947 shares of PD common stock. These shares are to be sold through Morgan Stanley Smith Barney LLC, with an approximate sale date of July 16, 2026 and listing on the NYSE.

What aggregate market value of PD shares is disclosed in the Form 144?

The filing states an aggregate market value of $4,288,680.25 for the 398,947 PD common shares. This figure reflects the market value used for the proposed sale described in the notice, not the company’s total equity value.

When is the approximate sale date for the PD shares in this notice?

The proposed sale of PD common stock is targeted for around July 16, 2026. This date appears as the approximate sale date both in the securities information section and in the acquisition/payment details for the shares to be sold.

Which broker is listed to handle the proposed PD share sales?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004. This firm is specified as the brokerage handling the proposed sale of 398,947 PD common shares on the NYSE.

What 10b5-1 sales of PD stock occurred in the past three months?

The notice lists 10b5-1 sales for Jennifer Gail Tejada of 105,101 shares of common stock on May 19, 2026 for $727,383.00, and 358,400 shares on May 18, 2026 for $2,502,563.84, reflecting earlier transactions in the same issuer’s stock.

How many PD shares outstanding are referenced in the Form 144?

The filing references 77,122,565 shares outstanding for the issuer’s common stock. This figure provides context for the size of the proposed 398,947-share sale relative to the total outstanding equity noted in the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 04:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001736979
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PAGERDUTY INC
SEC File Number	001-38856
Address of Issuer	600 Townsend St., Suite 200 San Francisco CALIFORNIA 94103
Phone	8448003889
Name of Person for Whose Account the Securities are To Be Sold	JENNIFER GAIL TEJADA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	398947	4288680.25	77122565	07/16/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/16/2026	Exercise of Stock Options	Issuer			398947	07/16/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JENNIFER GAIL TEJADA 600 Townsend St., Suite 200 San Francisco CA 94103	Common	05/19/2026	105101	727383.00
10b5-1 Sales for JENNIFER GAIL TEJADA 600 Townsend St., Suite 200 San Francisco CA 94103	Common	05/18/2026	358400	2502563.84

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	07/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Tejada
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)